微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 3.03% | -43.78% | 99.34% | 14/142 | 5.78% | 三鑫医疗 | 13.46% | 行业排名> |
| 2026-06-30 | 1.52% | -57.78% | 12.59% | 68/142 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.35% | -16.15% | -53.29% | 61/142 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.89% | -56.8% | -46.38% | 69/142 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 5.39% | -9.11% | 49.72% | 53/142 | 4.18% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.6% | -10% | 123.6% | 46/142 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.61% | -6.4% | -75.93% | 54/142 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 6.69% | -1.76% | 12.82% | 52/142 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.93% | 1.72% | 48.25% | 48/142 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4% | 18.69% | 132.56% | 50/142 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.72% | 16.22% | -74.74% | 58/142 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 6.81% | 141.49% | 16.81% | 64/142 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 5.83% | 103.85% | 73% | 57/142 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 3.37% | 258.51% | 127.7% | 66/142 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.48% | 37.04% | -47.52% | 73/142 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 2.82% | -51.55% | -1.4% | 106/142 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 2.86% | -48.28% | 204.26% | 101/142 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 0.94% | -75.96% | -12.96% | 110/142 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.08% | -38.29% | -81.44% | 85/142 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 5.82% | 54.38% | 5.24% | 106/142 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 5.53% | 167.15% | 41.43% | 90/142 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.91% | 2692.86% | 123.43% | 92/142 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.75% | 480.43% | -53.58% | 81/142 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 3.77% | -57.78% | 82.13% | 113/142 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 2.07% | -68.1% | 1378.57% | 79/142 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 0.14% | -97.21% | 130.43% | 102/142 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -0.46% | 2% | -105.15% | 69/142 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 8.93% | -19.11% | 37.6% | 84/142 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 6.49% | 2% | 29.54% | 43/142 | 10.54% | XD祥生医 | 28.56% | 行业排名> |
| 2019-06-30 | 5.01% | 2% | -54.62% | 46/142 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 11.04% | -3.58% | -3.58% | 65/142 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 11.45% | 8.43% | 8.43% | 60/142 | 14.51% | 安旭生物 | 48.71% | 行业排名> |
| 2016-12-31 | 10.56% | 2% | 2% | 53/142 | 16.44% | 迈瑞医疗 | 38.33% | 行业排名> |